Choose your screen resolution: Auto adjust 800x600 1024x768

Information

Login

No account yet? Register

Please Visit

Advertisement

Question about CR and need for continued treatment - part 1

I have been wondering about complete response to a treatment, whether it be SCT or use of chemo, and the need for continued use of drugs or other treatment afterwards. I've noticed that some people have just Zometa or Aredia, while others will stay on a steroid or some other drugs. Once you have total remission, is it necessary to stay on drugs? My goal is to not have to take anything for as long as possible. Will that be a possibility for me?

I posted this question to the ACOR MM mailing list and wanted to share some of the answers I received. They certainly merit a great deal of consideration. (Posted with permission.)

Answer:

In my opinion Beth, if the disease stays down without treatment, it is in remission. If it starts to rebound upon withdrawal of treatment, it is a response. Just semantics to some but to me it is a clear difference.

It is true that many take a treatment to try and 'extend' the remission. IMO, one needs to choose such treatments carefully. Many have taken Thalidomide for maintenance. I think this is a poor choice, because Thal' is toxic and has definite permanent PN associated with its use. To take Thal' and get the side effects not knowing if it is really holding disease back is, to me, not wise.

Aredia/Zometa have anti-myeloma effects along with helping to strengthen the skeleton. Other, less troublesome maintenance drugs may include, IL6 suppressors like Biaxin.

Don S.

Search This Site

Tax Deductible Donation

Please support this site and online support for health challenges of all kinds, which are provided by the Online Patient Empowerment Project, a 501(c)(3) Corporation.

Search the Web

Google

Mailing Lists

Have you subscribed to the MMA interactive mailing list?  Please click HERE to subscribe. Once subscribed, you can choose a daily digest version, real time delivery and you'll have access to the list archives. To join the ACOR list, please click HERE.

Syndicate

Statistics

Who's Online

We have 15 guests online